About Us

Our Mission

The leading cloud-based enterprise platform enabling continuous digital care to transform management of chronic and complex conditions.

We founded Medocity in 2013 with a singular vision to make virtual care a seamless and ubiquitous reality across the entire healthcare landscape. We believed this would be a game-changer for patients, supporting and keeping them healthier when they’re at their most vulnerable – at home, on their own, or anywhere where they don’t have easy access to care professionals. From that lofty beginning, we’ve built a dedicated and vibrant company bringing to market the most comprehensive and flexible digital care ecosystem available today. Our core mission is the foundation of our client promise: The Medocity Platform enables the delivery of truly patient-centered care resulting in high engagement, greater patient satisfaction, and ultimately better outcomes.

Management Team



Chief Executive Officer & President

Raj founded Medocity with the vision to enrich the care of patients at home and reduce total health care costs leveraging next generation virtual technology. He has more than 20 years of global executive leadership experience including 8 years in the Oncology space. At Novartis Biologics, Raj was Chief Financial Officer and Global Head of Strategy and Operations where he built a $10 billion global business. He has also held key senior executive roles at Medco Health Solutions, Pharmacia, and Warner Lambert, and he was the founder/CEO of Logon Health, an early entry electronic prescribing venture.  Raj holds an MBA in Finance from NYU’s Stern School of Business and BS in Electrical Engineering.

Raj Agarwal LinkedIn  email  

Raj Agarwal

Chief Executive Officer
and President



Global Head, Clinical Trials Digital Solutions

Amalia "Amy" Apostoleris is a recognized leader in operations and business development with over 30 years of experience in healthcare and biopharmaceutical development leading organizations and driving innovative solutions that benefit and improve the health and lives of patients and their families while generating value for all stakeholders through corporate growth and expanding industry presence. Amy’s prior experience includes Pfizer Inc, ICON, Syneos Health, CT Health Systems Agency, Harvard Clinical, and Sandler Occupational Medicine Associates. She earned an MA in Education and Life Sciences, a BA in Human Ecology, and an MBA in Pharmaceutical Development and Healthcare. She holds leadership positions within the Healthcare Business Women's Association (HBA) and is a key member of the DTRA Leadership Council working with industry leaders in establishing KPIs for decentralized clinical trials. Amy is passionate in both her professional and personal careers supporting healthcare communities while enjoying the outdoors.

Amy  email  

Amy Apostoleris

Global Head,
Digital Clinical Trials Solutions 



Global Head, Digital PSP Solutions

Loreen began her career as a social worker, and as such, always puts the patient in the center of all she does. With over 25 years of experience in the specialty healthcare industry, she has supported the launch and market access of over 100 products. During her tenure at AmerisourceBergen Corporation she held executive leadership positions at Lash Group and Xcenda, leading their company strategy, commercialization and new product adoption and implementation efforts, the development of AI-related products, adherence and other patient support programs, commercial copay and ACE services, while expanding efforts within oncology, orphan drugs, non-profit operations, diagnostics and global reach. She also held leadership positions at Bayer and Sanofi at which she led teams and initiatives to create innovative and meaningful support programs designed to transform the complex healthcare system into practical and streamlined patient access solutions. Loreen received her B.S. in Biology from the University of Illinois Champaign-Urbana and her Masters in Social Work, Policy, Planning, and Administration from The Catholic University of America.

Loreen  email  

Loreen Brown

Global Head,
Digital PSP Solutions



VP, Market Strategy & Commercialization

Terry is responsible for developing and building commercialization strategies and strategic client relationships. He joined Medocity after 20+ years as an executive with Medco Health Solutions, CVS Health, United Biosource Corporation, and Time Warner where he gained broad connected health experience and deep digital business expertise developing strategies, products and services for patients, providers, payers, and caregivers. A classically trained all-state cellist and guitarist, he also pursued a brief, early calling as a professional touring musician and recording artist. Terry earned an MBA in Strategy and Finance from the Wharton School at the University of Pennsylvania and a BS in Mechanical Engineering from Clarkson University.

Terry Maytin  email  

Terry Maytin

VP, Market Development
and Commercialization



Senior Director, Clinical Services

Laura leads Medocity’s Clinical Services team with over 20 years of healthcare management and nursing leadership experience. She provides clinical leadership and oversight in collaboration with client project teams, business leads, and medical affairs developing clinical protocols, resources and content to support client-specific program requirements. Prior to joining the Medocity team, Laura served in several senior management roles with Atlantic Health Systems, Novartis Pharmaceutical Corporation, Hackensack Medical Center, and Newark Beth Israel Medical Center. Laura has a BS in psychology from Upsala College, an MPA from Fairleigh Dickinson University, and earned her nursing diploma from Clara Maass School of Nursing. She also holds a certificate in Health Care Administration and is Six Sigma certified.

Laura Giostra, RN

Sr. Director,
Clinical Services



VP, Operations

Tom is an established operational leader with over 30 years of experience helping drive innovative client solutions, business strategy and execution. He oversees Medocity’ business operations support, client implementations, client life cycle management, operational infrastructure and project management functions. Prior to Medocity, he held various management roles and leadership responsibilities with Express Scripts/CIGNA working within their Sales & Account Management Organization focusing on new client implementations, upsell solutions, day to day operational support for existing clients, and other transformational initiatives. Tom graduated from Ramapo College of New Jersey with a B.A in Economics.


Tom Hansell

VP, Operations
and Implementation

Technology Leadership



Chief Technology Officer

Anil has over 20 years of experience in convergent technologies developing mobility and collaborative applications. Prior to Medocity, Balani was SVP of Technology at Glowpoint where he led all aspects of R&D, product development, and engineering for telepresence and video cloud computing. He has also held senior technology leadership roles at UTC Associates, Global Crossing, MCI, AT&T/Teleport Communications, and Texas Instruments. Anil holds an MS and MSEE from Southern Methodist University, and MBA from the University of Dallas, a BEE from Cooper Union, and a BS from NYU.


Anil Balani

Chief Technology



Chief Architect

Andreas serves as Chief Architect for Medocity's mobile healthcare cloud platform. Previously, he was Director of Cloud Application Development at Glowpoint responsible for video as a service and collaboration technologies supporting high end Immersive Telepresence to mobile video.  Andreas has extensive mobile and social networking development expertise including incorporation of gamification methodologies in mobile enterprise applications.  Andreas also designed and developed the first retail video banking solution for Citibank and has been awarded multiple patents.  Andreas attended University of Skövde, Sweden.

Andreas Eriksson LinkedIn

Andreas Eriksson




Managing Director, India

Imran serves as Managing Director for India overseeing all areas of operations and development at Medocity’s Indian subsidiary. He has more than 20 years of global experience in Information Technology with Tata Consultancy Services and Cognizant Technology Solutions in various executive, management, technical and sales roles. He has worked extensively in the Banking, Financial Services, Insurance, Health Care, Media, Shipping and Hospitality segments, with clients such as P&O, Wyndham RCI, JP Morgan & Chase, Deutsche Bank, NBC and State Farm. Imran has also worked on corporate initiatives including business excellence modeling and balanced scorecards.

Imran Kazimi LinkedIn

Imran Kazimi

Managing Director,
India Team

Strategic Advisory Board

Robert Epstein, MD
Formerly the President of United Biosource Corporation and Chief Medical Officer at Medco, Dr. Rob is an epidemiologist by training with extensive expertise in personalized medicine, drug safety, and health economics and clinical outcomes research. He is also the former President of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Dr. Epstein serves on the Board of Directors of Fate Therapeutics, Veracyte, Proteus Digital Health, Mindstrong, Intellos, and Illumina. Dr. Epstein has published more than 75 peer-reviewed medical articles and serves as a reviewer for the New England Journal of Medicine.
Raj Garg, MD, JD

Formerly the President & CEO of Cancer Treatment Centers of America, Dr. Garg is a highly-respected industry leader with more than 25 years of global healthcare experience. As Senior Partner at McKinsey & Company, he worked with biopharma, medical products, providers, payers, and ancillary service companies, guiding executive leadership through transformational change by spearheading strategic growth and business development initiatives across the corporate value chain as well as a broad range of C-suite topics. Prior to McKinsey, he was a practicing health care attorney and completed his internship in internal medicine.

Josh Goode

Josh Goode is Chief Information Officer at SCAN, one of the largest not-for-profit Medicare Advantage plans in the country, responsible for the company’s Digital Strategy, Business Intelligence, IT Infrastructure, Electronic Data Interchange (EDI), and Application Development efforts. During his previous 15-year tenure with Accenture, Josh worked with several health plans throughout the United States, analyzing, planning, and implementing a variety of technological improvements and leading large technology systems implementations and IT transformations.

William Klitgaard
Bill Klitgaard has dedicated two decades of his career to leading and advising top healthcare companies. Mr. Klitgaard most recently served as President of Enlighten Health, a division of LabCorp focused on innovation and the creation of new information-based services. Previously, he spent 19 years at Covance, one of the world’s largest contract research organizations, serving as Chief Financial Officer and Chief Information Officer. Mr. Klitgaard earned a B.A. in economics from UC Berkeley and a Master’s degree from the Sloan Management School, Massachusetts Institute of Technology.
Suresh Kumar
Mr. Kumar has over 40 years of healthcare leadership including senior executive committee roles at Sanofi, J&J, and Warner-Lambert. He also led Oliver Wyman’s Public Sector & Life Sciences consulting practice. His background spans both the business and the public silos of consumer healthcare, Suresh was appointed by President Obama to be the Assistant Secretary of Commerce in 2010. He also served as Director General overseeing the US and Foreign Commercial Service (USFCS) and leading the US National Export Initiative. Suresh is a Distinguished Professor of International Business at George Washington University.
Sukumar Nagendran, MD
Recently the Chief Medical Officer at AveXis Inc. and member of senior executive team responsible for launching the firm’s successful IPO and subsequent $8B acquisition by Novartis in 2018. He was responsible for working with the FDA to obtain BTD (breakthrough therapy designation), PRIME designation in the EU and SakiGake designation in Japan for AVXS-101 gene therapy for SMA-1. He has over 30 years of experience with gene therapy development, clinical development strategy, medical affairs and diagnostics. He currently serves on board of Solid Biosciences, advisor to Chardan & Encoded Therapeutics
Marshall Welch III
Mr. Welch has diverse industry experience with companies ranging from $2.0 million to over $12.0 billion in revenue, serving as corporate officer (CEO, CFO & COO) and advisor to emerging growth companies in the medical device development, cancer research, healthcare information technology and banking industries located in Europe, Asia, and the U.S. He has held senior finance and operations positions with responsibility in Germany, Hungary, Switzerland, Holland, Russia and the USA, and he holds two U.S. patents for medical devices which were sold to a NYSE listed company.

Medical Advisory Board

Pankaj Bhargava, MD

Robert Friedman, MD

Anandhi Johri, MD

Mohit Narang, MD

Maithili Rao, MD

Sarah Zakneon, MD